Fundación Althaia Manresa Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2007
NCT00906061
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Althaia Xarxa Assistencial de Manresa | Althaia Xarxa Assistencial Universitària de Manresa | Althaia Xarxa Assitencial de Manresa | Althaia, Xarxa Universitaria i assistencial de Manresa | Amager-Hvidovre Universitetshospital | Hospital Althaia, Xarxa Asistencial de Manresa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Prostatic Neoplasms (Phase 3)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8